SYNTA PHARMACEUTICALS CORP.
Patent Owner
Stats
- 118 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 118 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,894 Total Citation Count
- May 22, 1998 Earliest Filing
- 153 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0340,652 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH CHK INHIBITORSAug 11, 17Nov 30, 17[A61K]
2016/0324,863 TARGETED CANCER TREATMENT BY HSP90 INHIBITORS GANETESPIB AND NVP-AUY922Jan 16, 15Nov 10, 16[A61K, C12Q]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9439899 Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitorsNov 01, 12Sep 13, 16[A61K]
9205086 Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitorApr 19, 11Dec 08, 15[A61K]
9174935 Transition metal complexes of bis[thiohydrazide amide] compoundsOct 21, 09Nov 03, 15[A61K, C07D, C07C, A61P]
9175022 Compounds for the treatment of proliferative disordersAug 01, 13Nov 03, 15[A61K, C07F, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0283,147 TREATING POLYCYSTIC KIDNEY DISEASE WITH HSP90 INHIBITORY COMPOUNDSAbandonedOct 18, 13Oct 08, 15[A61K]
2015/0253,330 PRE-SELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH AN HSP90 INHIBITOR BASED ON HYPOXIC STATUSAbandonedOct 15, 14Sep 10, 15[C12Q, G01N]
2015/0119,395 NOVEL TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITYAbandonedApr 04, 13Apr 30, 15[C07D]
2015/0099,721 TREATING CANCER WITH HSP90 INHIBITORY COMPOUNDSAbandonedMay 10, 13Apr 09, 15[A61K, C07F, C07D]
2015/0005,320 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedSep 27, 13Jan 01, 15[C07D, C07C]
2014/0363,830 COMPOUNDS THAT MODULATE HSP90 ACTIVITY AND METHODS FOR IDENTIFYING SAMEAbandonedMar 05, 14Dec 11, 14[G01N]
2014/0342,999 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERSAbandonedMay 19, 14Nov 20, 14[A61K, C07C]
2014/0329,892 ADMINISTRATION OF A BIS(THIOHYDRAZIDE AMIDE) COMPOUND FOR TREATING CANCERSAbandonedNov 09, 12Nov 06, 14[A61K, C07C]
2014/0315,943 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MTOR/P13K INHIBITORSAbandonedMay 23, 12Oct 23, 14[A61K, C07D]
2014/0296,176 COMBINATION CANCER THERAPY WITH AN HSP90 INHIBITOR AND AN ANTIMETABOLITEAbandonedAug 17, 12Oct 02, 14[A61K, A61N]
2014/0286,902 COMBINATION THERAPY OF HSP90 INHIBITORS WITH PLATINUM-CONTAINING AGENTSAbandonedNov 01, 12Sep 25, 14[A61K]
2014/0248,299 VINYL-PHENYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMay 09, 14Sep 04, 14[C07D, C07C]
2014/0242,120 SUBSTITUTED AROMATIC COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMay 08, 14Aug 28, 14[C07D, C07C]
2014/0228,418 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH MEK INHIBITORSAbandonedMay 22, 12Aug 14, 14[A61K]
2014/0194,388 COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH CHK INHIBITORSAbandonedMay 25, 12Jul 10, 14[A61K]
2014/0187,586 PYRIDYLPHENYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMar 12, 14Jul 03, 14[C07D]
2014/0178,366 PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT BASED ON HYPOXIC STATUSAbandonedDec 17, 13Jun 26, 14[A61K, G01N, C07K]
2014/0135,331 THIAZOLE AND THIADIAZOLE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USESAbandonedMay 16, 13May 15, 14[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
